Ten prognostic beneficial factors of the heterogeneous expression of lung squamous cell carcinoma genes driven by TTN mutations were screened for and DLX5, FEZF1, H2BC9, EREG, and SLC34A2 were identified as the main factors of the prognostic models. This evidence concerns the gene H2BC9 and squamous cell lung carcinoma.